You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

[C04.588.180]

Showing 1 - 25 of 2,770
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

C04.588.274.476.411.307 Trial (CPI-613, modified FFX, Bevacizumab)

Not yet recruiting
  • C04.588.274.476.411.307
  • (no location specified)
Nov 10, 2022

C04.588.274.476.411.307 Trial in Denmark, Sweden (Oxaliplatin (Eloxatin), Capecitabine (Xeloda))

Completed
  • C04.588.274.476.411.307
  • Oxaliplatin (Eloxatin)
  • Capecitabine (Xeloda)
  • Esbjerg, Denmark
  • +7 more
Nov 4, 2020

Breast Tumors Trial in France (MAG-TN3 + AS15)

Completed
  • Breast Neoplasms
  • MAG-TN3 + AS15
  • Lyon, France
  • +4 more
Mar 21, 2022

Hypertension, Pulmonary Trial in Worldwide (Tadalafil, Placebo, ERA as specific PAH treatment)

Completed
Has Results
  • Hypertension, Pulmonary
  • Atlanta, Georgia
  • +42 more
Nov 3, 2021

Hepatitis B Trial in Worldwide (GSK3228836, Placebo, Nucleos(t)ide therapy)

Completed
  • Hepatitis B
  • Los Angeles, California
  • +120 more
Jul 1, 2022

Atopic Dermatitis Trial in Worldwide (Baricitinib, Placebo)

Active, not recruiting
Has Results
  • Atopic Dermatitis
  • Caba, Buenos Aires, Argentina
  • +184 more
Jun 7, 2022

Relapsing Multiple Sclerosis Trial in Worldwide (Interferon beta-1a, Ocrelizumab-matching , Ocrelizumab)

Active, not recruiting
Has Results
  • Relapsing Multiple Sclerosis
  • Interferon beta-1a
  • +3 more
  • Phoenix, Arizona
  • +140 more
Jan 2, 2023

Autoimmunity, Inflammation Trial in Worldwide (Secukinumab s.c. injection)

Recruiting
  • Autoimmunity, Inflammation
  • Secukinumab s.c. injection
  • Fullerton, California
  • +93 more
Jul 14, 2022

Covid19, Coronavirus Trial in London (Corsodyl® Alcohol free -0.2 % Chlorhexidine digluconate, Colgate Peroxyl® -1.5% Hydrogen

Completed
  • Covid19
  • Coronavirus
  • Corsodyl® Alcohol free -0.2 % Chlorhexidine digluconate
  • +3 more
  • London, United Kingdom
  • +1 more
Sep 12, 2022

Gut-Brain-axis: Targets for Improvement of Cognition in Elderly

Recruiting
  • Type 2 Diabetes Mellitus
  • Girona, Spain
    Institut d'Investigació Biomèdica de Girona (IDIBGI)
Nov 15, 2022

Ulcerative Colitis Trial in Worldwide (Etrasimod, Placebo)

Completed
Has Results
  • Ulcerative Colitis
  • Dothan, Alabama
  • +314 more
Nov 28, 2022

Cytokine Storm Among Bangladeshi Patients With COVID-19

Not yet recruiting
  • Cytokine Storm, COVID-19
    • Dhaka, Bangladesh
      Icddr,B
    Apr 12, 2022

    Pancreas Adenocarcinoma Trial in Worldwide (NovoTTF-100L(P), Gemcitabine, nab paclitaxel)

    Recruiting
    • Pancreas Adenocarcinoma
    • NovoTTF-100L(P)
    • +2 more
    • Birmingham, Alabama
    • +145 more
    Aug 10, 2022

    Prostate Cancer Trial in Jacksonville (< 15% risk of + LN, > 15% risk of + LN)

    Active, not recruiting
    Has Results
    • Prostate Cancer
    • < 15% risk of + LN
    • > 15% risk of + LN
    • Jacksonville, Florida
      University of Florida Proton Therapy Institute
    Dec 1, 2021

    Dermatitis, Dermatitis, Atopic, Eczema Trial in Worldwide (PF-04965842 100 mg, PF-04965842 200 mg, Placebo)

    Completed
    Has Results
    • Dermatitis
    • +9 more
    • PF-04965842 100 mg
    • +2 more
    • Birmingham, Alabama
    • +234 more
    Sep 17, 2021

    Atherosclerotic Cardiovascular Disease Trial in Worldwide (Lp(a) Screening)

    Recruiting
    • Atherosclerotic Cardiovascular Disease
    • Lp(a) Screening
    • Birmingham, Alabama
    • +670 more
    Feb 1, 2023

    Atezolizumab Under Real-World Conditions in Patients Treated in

    Recruiting
    • Urothelial Carcinoma
    • +3 more
    • Buenos Aires, Argentina
    • +322 more
    Dec 19, 2022

    Advanced Breast Cancer Trial in Worldwide (Ribociclib, fulvestrant, Ribociclib )

    Active, not recruiting
    Has Results
    • Advanced Breast Cancer
    • Mobile, Alabama
    • +173 more
    Aug 4, 2022

    Epithelial Barrier Integrity in Biologic Treatment Response of

    Not yet recruiting
    • Severe Eosinophilic Asthma w/wo CRSwNP
    • Mepolizumab 100 MG
    • Heraklion, Crete, Greece
      "PAGNI" University Hospital, Crete
    May 3, 2022

    Metastatic Castrate Resistant Prostate Cancer (mCRPC) Trial in Worldwide (Radium-223 dichloride (Xofigo, BAY88-8223), NAH

    Recruiting
    • Metastatic Castrate Resistant Prostate Cancer (mCRPC)
    • Radium-223 dichloride (Xofigo, BAY88-8223)
    • NAH therapy
    • Castle Hill, New South Wales, Australia
    • +156 more
    Jan 13, 2023

    Type 2 Diabetes, Obese, Overweight Trial in Lasalle, London (Release)

    Recruiting
    • Type 2 Diabetes
    • +2 more
    • Release
    • Lasalle, Ontario, Canada
    • +1 more
    Apr 25, 2023

    Aging (ROBRA) in a Special Operations Forces Cohort

    Active, not recruiting
    • Post-Traumatic Stress Disorder
    • Traumatic Brain Injury
    • subanesthetic ketamine infusions and bilateral cervical sympathetic blocks
    • Westmont, Illinois
      Stella Center
    May 2, 2023

    Obese, Overweight Trial in Lasalle, London (Release)

    Recruiting
    • Obese
    • Overweight
    • Release
    • Lasalle, Ontario, Canada
    • +1 more
    Apr 25, 2023

    Hyperlipemia Trial in Beijing (RBD7022, Placebo)

    Recruiting
    • Hyperlipemia
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Jun 12, 2023

    Ulcerative Colitis Trial in Worldwide (Placebo, Guselkumab)

    Active, not recruiting
    • Ulcerative Colitis
    • Lancaster, California
    • +390 more
    Jan 17, 2023